Background | Overview | Letter of Intent | Full Application and Review Criteria | Critical Path


The CBCRP completed a comprehensive, three-year priority setting process in 2004 to re-evaluate the progress made during the first decade of our grant funding effort. A new perspective and consensus emerged that allowed the Program to: (i) identify our strengths and weaknesses, (ii) select the areas (research topics and award types) to best leverage our funds for maximum impact over the next 3-5 years, (iii) establish new priorities and directions to impact breast cancer in California, and (iv) place the CBCRP in a unique niche to avoid overlap with other breast cancer funding agencies.

The visible outcome of the 2004 priority setting process was to separate CBCRP’s research activities into three divisions for maximum effectiveness:

As part of the 2004 re-organization, the CBCRP discontinued a number of award types, including the Translational Research Collaboration (TRC) that was offered from 1997 through 2004 (Cycles 3-11). Why was CBCRP unhappy with the previous TRC award type and felt compelled to construct a replacement? After funding TRCs from 1997-2004, the following deficiencies were noted:

Thus, the CBCRP advisory Council worked with the Program staff from 2005-2006 to develop a replacement for the TRC award type. These changes emerged from this process:

We hope this background will explain our rationale for the content of the new Translational Research Award and format for the application/review process as presented in the following sections. We encourage you to keep these programmatic issues in mind as you decide whether to apply and develop a strategy to submit an application.